UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world’s biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
On Friday, UNICEF posted on its Web site the actual prices that it has paid individual drugmakers for 16 vaccines purchased over the last decade. It is a move that some Western pharmaceutical companies do not support. Novartis AG and Merck & Co, which only sells one of its many children’s vaccines to UNICEF, both declined to have their prices published.
UNICEF said it would continue to disclose pricing of future vaccine deals, with the hope that the transparency will push drugmakers to cut prices and thus allow the organization to vaccinate more children and save more lives.
“Transparency will also help foster a competitive, diverse supplier base,” said Shanelle Hall, director of UNICEF’s supply division.
She said that it would also help UNICEF’s partners and those governments that buy vaccines on their own to make more informed decisions in price negotiations with drugmakers.
UNICEF last year spent US$757 million to provide 2.5 billion doses of vaccines to 99 countries, reaching an estimated 58 percent of the world’s children.
Its price list shows significant disparity, with Western drugmakers often charging UNICEF double what companies in India and Indonesia do. Just as striking is the steady rise in prices in the last decade, with the cost of vaccines against measles, polio and tetanus roughly doubling between 2001 and last year. Prices of some vaccines have remained flat or declined as additional competitors entered the market.
There is also a huge spread in prices among various vaccines.
As might be expected, shots that have been around for some time and those vaccines made by multiple companies cost just pennies per dose, such as tetanus and tuberculosis shots and oral polio vaccine. However, a combination shot for immunization against diptheria, tetanus, whooping cough, hepatitis B and haemophilus influenza can run UNICEF US$3 or more per dose. The dual vaccine against 10 or more strains of pneumococcal disease, which causes ear infections and meningitis, costs US$3.50 a shot. And some of the vaccines require more than one booster shot, adding to the cost.
The cost is partly justified by the complex manufacturing process used to make combination vaccines. And UNICEF still pays far less than the US$71 and US$114 per dose, respectively, that is charged in the US for those two vaccines. However, given that the organization’s mission is to immunize entire populations of at-risk children, any savings means more can be vaccinated.
British drugmaker GlaxoSmithKline PLC said in a statement that it “always offers UNICEF our vaccines at our lowest price as they are targeted at the people who need them the most, but are least able to pay. We welcome UNICEF’s move to publish retrospective prices for tenders and hope that this will help inform decisions for future vaccine procurement.”
Messages left with other Western vaccine makers seeking comment were not immediately -returned on Saturday afternoon.
Daniel Berman, deputy director of the Doctors Without Borders Campaign for Essential Medicines, called the new price disclosures “a real step forward.”
“By getting access to these prices, buyers will be able to take advantage of the increasing capacity of emerging countries to develop and produce quality vaccines at significantly lower costs,” he said in a statement.
He added that the Global Alliance for Vaccines and Immunization (GAVI) “should flex its purchasing muscles to encourage manufacturers” to produce vaccines that do not require refrigeration and can be administered through patches or liquids, rather than needles.
GAVI, which is supported by contributions from developed nations and the Bill & Melinda Gates Foundation, is the primary funder of vaccines purchased by UNICEF.
Helen Evans, interim CEO of GAVI, said in a joint statement with UNICEF that GAVI “strongly believes in timely, transparent and accurate information on pricing.”
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last